Contemporary Therapeutic Strategies for Solid Tumors
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 26 July 2026
Special Issue Editor
Interests: hematologic malignancies; stem cell transplantation; immunotherapy; CAR-T cell therapy; multiple myeloma; leukemia and lymphoma; precision medicine; novel therapeutics; hematopoietic stem cells; drug resistance in cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue addresses contemporary therapeutic strategies and survival outcomes in severe diseases, with a primary focus on solid tumors. As advances in cancer treatment continue to evolve rapidly, there is a critical need to evaluate both innovative therapeutic approaches and their impact on patient survival and long-term outcomes.
We invite original research articles, systematic reviews, meta-analyses, and clinical studies that examine cutting-edge treatment modalities and survival analysis across a diverse range of solid tumors, including but not limited to nasopharyngeal carcinoma, rectal cancer, breast cancer, lung cancer, gastric cancer, and hepatocellular carcinoma. This Special Issue particularly welcomes submissions exploring targeted therapy, immunotherapy, precision medicine, combination treatment regimens, and emerging cellular therapies for solid tumors, alongside comprehensive survival analyses that provide insights into prognostic factors and treatment efficacy.
The scope encompasses both prospective and retrospective studies that evaluate treatment outcomes for solid tumors, comparative effectiveness research, real-world evidence, and translational studies bridging laboratory discoveries to clinical applications. We encourage investigations into treatment-related survival benefits, quality of life assessments, biomarker-guided therapeutic decisions, and strategies to overcome treatment resistance in the context of solid malignancies.
This Special Issue aims to serve as a comprehensive resource for clinical physicians, oncologists, and researchers seeking to understand current best practices and emerging paradigms in the management of solid tumors. By integrating therapeutic innovation with rigorous survival analysis, we hope to contribute meaningful insights that will enhance clinical decision-making and ultimately improve patient outcomes in the face of these life-threatening malignancies.
Dr. Chohao Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapeutic strategies
- survival analysis
- solid tumors
- cancer treatment
- targeted therapy
- immunotherapy
- precision medicine
- clinical outcomes
- prognostic factors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
